Leflunomide exposure through second trimester of pregnancy: A case report.

Alothman, Rawan; Yeung, James; Waterman, Elizabeth; Lepik, Christa; Amiri, Neda

Alothman, Rawan; Yeung, James; Waterman, Elizabeth; Lepik, Christa; Amiri, Neda.

Afiliación

Alothman R; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Yeung J; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Waterman E; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Lepik C; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Amiri N; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Birth Defects Res ; 115(16): 1566-1569, 2023 10 01.

Article en En | MEDLINE | ID: mdl-37462087

Asunto(s)

Artritis Reumatoide; Resina de Colestiramina; Humanos; Embarazo; Femenino; Leflunamida; Segundo Trimestre del Embarazo; Isoxazoles/efectos adversos

Palabras clave

Leflunomide; pregnancy; rheumatoid arthritis; teratogen

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Resina de Colestiramina Límite: Female / Humans / Pregnancy Idioma: En Revista: Birth Defects Res Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google